These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17153907)

  • 61. Evaluation of the response of unresectable carcinoid tumors to radiotherapy.
    Samlowski WE; Eyre HJ; Sause WT
    Int J Radiat Oncol Biol Phys; 1986 Mar; 12(3):301-5. PubMed ID: 3082806
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Survival Benefit of Adjuvant Chemotherapy in Pulmonary Carcinoid Tumors.
    Sobash PT; Ullah A; Karim NA
    Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230651
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Objective response of malignant carcinoid to radiation therapy.
    Abrams RA; King D; Wilson JF
    Int J Radiat Oncol Biol Phys; 1987 Jun; 13(6):869-73. PubMed ID: 3583857
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Stereotactic radiotherapy in the treatment of primary bronchial carcinoid tumor.
    Colaco RJ; Decker RH
    Clin Lung Cancer; 2015 Mar; 16(2):e11-4. PubMed ID: 25591327
    [No Abstract]   [Full Text] [Related]  

  • 65. Defining the role of adjuvant chemotherapy after lobectomy for typical bronchopulmonary carcinoid tumors.
    Nussbaum DP; Speicher PJ; Gulack BC; Hartwig MG; Onaitis MW; D'Amico TA; Berry MF
    Ann Thorac Surg; 2015 Feb; 99(2):428-34. PubMed ID: 25499480
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment].
    Langfort R; Rudziński P; Burakowska B
    Pneumonol Alergol Pol; 2010; 78(1):33-46. PubMed ID: 20162517
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inoperable Pulmonary Carcinoid Tumors: Local Control Rates With Stereotactic Body Radiotherapy/Hypofractionated RT With Image-Guided Radiotherapy.
    Singh D; Chen Y; Cummings MA; Milano MT
    Clin Lung Cancer; 2019 May; 20(3):e284-e290. PubMed ID: 30850224
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Advanced typical and atypical carcinoid tumours of the lung: management recommendations.
    Melosky B
    Curr Oncol; 2018 Jun; 25(Suppl 1):S86-S93. PubMed ID: 29910651
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Primary Pulmonary Carcinoid Tumor: A Long-term Single Institution Experience.
    Herde RF; Kokeny KE; Reddy CB; Akerley WL; Hu N; Boltax JP; Hitchcock YJ
    Am J Clin Oncol; 2018 Jan; 41(1):24-29. PubMed ID: 26270444
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The role of adjuvant therapy for atypical bronchopulmonary carcinoids.
    Wegner RE; Abel S; Hasan S; Horne ZD; Colonias A; Weksler B; Verma V
    Lung Cancer; 2019 May; 131():90-94. PubMed ID: 31027704
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Radiation therapy in the management of patients with malignant carcinoid tumors.
    Chakravarthy A; Abrams RA
    Cancer; 1995 Mar; 75(6):1386-90. PubMed ID: 7533655
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Early-Stage Primary Lung Neuroendocrine Tumors Treated With Stereotactic Body Radiation Therapy: A Multi-Institution Experience.
    Oliver DE; Laborde JM; Singh DP; Milano MT; Videtic GM; Williams GR; LaRiviere MJ; Chan JW; Peters GW; Decker RH; Samson P; Robinson CG; Breen WG; Owen D; Tian S; Higgins KA; Almeldin D; Jabbour SK; Wang F; Grass GD; Perez BA; Dilling TJ; Strosberg J; Rosenberg SA
    Int J Radiat Oncol Biol Phys; 2023 Jul; 116(4):849-857. PubMed ID: 36708788
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Role of Conventionally Fractionated Radiotherapy and Stereotactic Radiotherapy in the Treatment of Carcinoid Tumors and Large-Cell Neuroendocrine Cancer of the Lung.
    Bilski M; Mertowska P; Mertowski S; Sawicki M; Hymos A; Niedźwiedzka-Rystwej P; Grywalska E
    Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008341
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Stereotactic body radiation therapy versus fractionated radiation therapy for early-stage bronchopulmonary carcinoid.
    Wegner RE; Abel S; Horne ZD; Hasan S; Colonias A; Verma V
    Lung Cancer Manag; 2019 Aug; 8(3):LMT14. PubMed ID: 31807142
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Carcinoid Tumor Arising from the Sphenoid Sinus Treated with Definitive Intensity-modulated Radiation Therapy: A Case Report.
    Hilal L; Jammal M; Khalifeh I; Tfayli A; Youssef B
    Cureus; 2019 Mar; 11(3):e4288. PubMed ID: 31183269
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Carcinoid tumor of lung and BRCA mutation: a case report.
    Shariff MZ; Curras-Martin D; Campbell N; Gupta V; Mikhail JD; Levitt MJ; Hossain MA
    J Med Case Rep; 2019 May; 13(1):132. PubMed ID: 31039815
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Adjuvant Chemotherapy Does Not Confer Superior Survival in Patients With Atypical Carcinoid Tumors.
    Anderson KL; Mulvihill MS; Speicher PJ; Yerokun BA; Gulack BC; Nussbaum DP; Harpole DH; D'Amico TA; Berry MF; Hartwig MG
    Ann Thorac Surg; 2017 Oct; 104(4):1221-1230. PubMed ID: 28760471
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Massive parallel sequencing and digital gene expression analysis reveals potential mechanisms to overcome therapy resistance in pulmonary neuroendocrine tumors.
    Walter RF; Vollbrecht C; Christoph D; Werner R; Schmeller J; Flom E; Trakada G; Rapti A; Adamidis V; Hohenforst-Schmidt W; Kollmeier J; Mairinger T; Wohlschlaeger J; Zarogoulidis P; Porpodis K; Schmidt KW; Mairinger FD
    J Cancer; 2016; 7(15):2165-2172. PubMed ID: 27994651
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.